Voyager Acquisition Corp.
              
              
                Status: Live Deal
                
            
                  U=S+W/2
                  W=S@11.50
                  
                
              | IPO Proceeds, $M | $253.00M | 
|---|---|
| IPO Date | Aug 9, 2024 | 
| CEO | Adeel Rouf | 
| Left Lead | Cantor Fitzgerald | 
| IPO Cash in Trust | 100.5% | 
| SPAC Tenor | 24 months | 
| IPO Sector | Healthcare ▶ | 
| IPO Geography | Global | 
| Target Company | VERAXA Biotech | 
| Deal Announced | Apr 23, 2025 | 
| Deal Size, $M | $1,313.30M | 
| Deal Sector | Healthcare | 
| Deal Geography | Europe | 
| SEC Filings | www.sec.gov | 
| Approval Vote | TBD | 
| Amendment Vote | TBD | 
                
                
                
                  VACH
                
                
                
                
                  VACHU
                
                
                
                
                  VACHW
                
                
                
              
              
              
            | Price | $10.50 | 
|---|---|
| Last closing price | $10.49 | 
| H/L, today | $10.50 / $10.50 | 
| Volume, today | 2,164 | 
| Volume, 3-month avg. | N/A | 
  
    
    Sign up for Free Trial
    
  
  
  
        No credit card required
Sign in to view structure, cap table, and calendar of events.